glp-1-directed nmda receptor antagonism for obesity treatment GLP-1 Agonists and Research to Treat Overeating and Substance Use Disorders Glucagon-Like Peptide-1 Based Therapies: A

16

Solnul - Produces a prebiotic effect, increasing the abundance of Bifidobacterium and Akkermansia in the GI tract

Exenatide inhibits the growth of endometrial cancer ishikawa xenografts in nude mice

A large ongoing trial (expected to finish later this year) is examining whether tirzepatide can help people who have both obesity and chronic kidney disease, building on already-strong evidence for GLP-1 drugs' benefits for the kidneys and heart

These effects are critical for preventing neurodegeneration, boosting antioxidant defenses, and reducing neuroinflammation [262]

See how your recent doses may build and taper Add recent semaglutide or tirzepatide shots to see a simple half-life estimate of how they may overlap between dose days